The nutraceutical CDMO market size is USD 39.8 Bn in 2026.
The nutraceutical CDMO market is projected to grow at an 6% CAGR by 2033.
The nutraceutical CDMO market growth drivers include rising chronic-disease/preventive-health demand, outsourcing adoption by mid-market companies, and digital/AI-driven formulation innovation.
North America is the dominating region for the nutraceutical CDMO market.
Catalent, Lonza, Aenova Group, NUTRASCIENCE LABS, and Robinson Pharma are some leading industry players in the nutraceutical CDMO market.